Drug Abuse Sciences

About:

Drug Abuse Sciences develops and commercializes therapies for the treatment of alcohol and drug addictions.

Website: http://drugabusesciences.com

Top Investors: Andera Partners, National Institutes of Health, Partech, 3i Group, ABN AMRO Fund

Description:

Drug Abuse Sciences develops and commercializes therapies for the treatment of alcohol and drug addictions. It offers Naltrexone Depot, a sustained-release formulation of Naltrexone for the treatment of alcohol and opiate addictions; DAS-431 for the treatment of cocaine addiction; and Buprenorphine Depot, a sustained-release formulation of buprenorphine for the treatment of heroin and various opiate addictions. Drug Abuse Sciences is based in Menlo Park, California.

Total Funding Amount:

$98.1M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

1994-01-01

Founders:

Number of Employees:

Last Funding Date:

2007-07-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai